TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
Sign Up to like & getrecommendations! Published in 2024 at "Genes"
DOI: 10.1002/gcc.23261
Abstract: Chromosomal rearrangements involving Janus kinase 2 (JAK2) are rare but recurrent findings in lymphoid or myeloid neoplasia. Detection of JAK2 fusion genes is important as patients with aberrantly activated JAK2 may benefit from treatment with… read more here.
Keywords: partner jak2; novel fusion; tle3 novel; fusion ... See more keywords